JZ Capital Partners Completes Sale of Interest in Salter Labs

JZ Capital Sells Interests in US Microcap Portfolio to JZHL Secondary Fund (led by Hamilton Lane)

October 19, 2020

Industrial Services

JZ Capital Partners Limited agreed to sell its interests in several US microcap portfolio companies — including Flex Pack, Flow Controls, Testing Services, Felix Storch, Peaceable and TierPoint — to a newly formed vehicle, JZHL Secondary Fund LP, led by Hamilton Lane Advisors and managed by an affiliate of Jordan/Zalaznick Advisers. The transaction will deliver approximately US$90m in cash to JZ Capital (subject to adjustments) and a special limited partner interest in the secondary fund; proceeds will be used primarily to repay senior debt while JZ Capital retains upside through the special LP interest.

Sier Capital Partners and ILS Management Complete Management Buyout of Integrated Laboratory Systems (ILS)

September 14, 2020

Healthcare Services

Sier Capital Partners is supporting the management team of Integrated Laboratory Systems (ILS) in an acquisition of the company. ILS, a Research Triangle Park, North Carolina–based contract research organization that provides pre-clinical toxicology and product safety testing, will leverage Sier’s capital and operating expertise to support future growth.

Ampersand Capital Partners Majority Recapitalizes Julius Clinical Research

November 28, 2023

Healthcare Services

Ampersand Capital Partners has completed a majority recapitalization of Julius Clinical Research, a Zeist-based clinical CRO, to support geographic expansion and deepen the company's scientific and therapeutic expertise. The investment will help Julius grow its CRO services in CNS, renal, cardiometabolic and infectious disease areas and expand its footprint in Europe and North America.

Salona Global Medical Device Corporation Acquires South Dakota Partners, Inc.

May 21, 2021

Medical Devices

Salona Global Medical Device Corporation (TSXV:SGMD) has closed its acquisition of South Dakota Partners, Inc., and its Form S-1 registration statement was declared effective by the U.S. SEC. Subscription receipts issued by Salona Global and Brattle Finco were converted or exchanged into common shares and warrants; the company has filed final materials with the TSX Venture Exchange regarding a Change of Business.

Main Street Capital Recapitalizes Jorgensen Laboratories (JorVet)

March 31, 2022

Veterinary

Main Street Capital Corporation provided $36.4 million in a combination of first‑lien term debt and a minority equity investment to facilitate the recapitalization of Jorgensen Laboratories, LLC (JorVet). Main Street and an unnamed co‑investor partnered with the company’s existing owners and management to complete the transaction and support the business, a longtime supplier of veterinary equipment and supplies headquartered in Loveland, Colorado.

Ampersand Capital Partners Invests in Genezen Laboratories

January 5, 2021

Biotechnology

Ampersand Capital Partners has made a majority growth-equity investment in Genezen Laboratories, a cell and gene therapy CDMO, to fund completion of a 25,000 sq. ft. cGMP lentiviral vector production facility and expand process development and analytical testing capabilities. The capital will support Genezen's capability expansion across upstream/downstream processing, analytical testing, and cGMP vector production to serve early‑phase and growth-stage cell and gene therapy developers.